Heart Failure & Chronic Kidney Disease Therapies | scPharma

Support for Managing Complex Conditions

By integrating cutting-edge research with practical applications, we play a crucial role in transforming health care and delivering solutions for complex medical conditions.

Effectively Managing Chronic Conditions

By integrating cutting-edge research with practical applications, we play a crucial role in transforming health care and delivering solutions for complex medical conditions.

Our Innovation &

Therapeutic Areas

Complex Condition Management

Our efforts aim to address risk, prevent disease progression, and manage complications effectively. scPharmaceuticals focuses on the intricate connections between the heart and kidneys to develop therapies for patients with cardiorenal conditions such as chronic kidney disease (CKD) and heart failure.

See our flagship product, FUROSCIX® (furosemide injection) 80mg/10mL for Subcutaneous Use. 

Managing complex conditions like heart failure and CKD.

Patient-Driven

Cardiorenal Care

Complex Condition Management

Our efforts aim to address risk, prevent disease progression, and manage complications effectively. scPharmaceuticals focuses on the intricate connections between the heart and kidneys to develop therapies for patients with cardiorenal conditions such as chronic kidney disease (CKD) and heart failure.

See our flagship product, FUROSCIX® (furosemide injection) 80mg/10mL for Subcutaneous Use. 

Target Cardiorenal Areas

Home and Outpatient

Home and Outpatient

scPharmaceuticals leads in managing chronic conditions with a focus on patient-centric care, enhancing access to transformative therapies in outpatient settings. Our commitment to continuity, precision, and understanding patient needs makes us a key partner in improving health outcomes and expanding treatment reach, setting new industry standards for quality and accessibility.

Traditional Therapeutics

Traditional Therapeutics

scPharmaceuticals aims to provide treatments designed to address a range of cardiorenal conditions. These therapies are based on well-established protocols, ensuring that patients receive high-quality care that improves outcomes and manages the complexities of chronic conditions.

Drug/Device Combinations

Drug/Device Combinations

Drug-device combinations provide an integrated approach that streamlines treatment delivery for patients with cardiorenal conditions. By combining the effectiveness of medication with the convenience of device-based administration, we focus on convenience and improving adherence to therapy.

Diagnostics and Monitoring Devices

Diagnostics and Monitoring Devices

scPharmaceuticals is looking to partner with companies that provide diagnostic tools and monitoring devices. We recognize the value and importance that accurate, real-time insights provide into a patient’ s health. Our approach helps empower healthcare professionals to make informed decisions, leading to better management of cardiorenal conditions and more personalized care.

Late-Stage Developmental and Commercial Products

Late-Stage Developmental and Commercial Products

By optimizing productivity and efficiency without compromising on quality, we provide cost-effective solutions that prioritize patient outcomes, enhance HCP support, and deliver true value to all stakeholders.

Health Technology

Health Technology

scPharmacetuicals is looking to integrate advanced health technology to support patient care in outpatient settings. By leveraging these technologies, we aim to enhance treatment access, streamline patient monitoring, and improve overall care for individuals with cardiorenal conditions.